Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2026 · 10-Q
Revenue$4.73M$4.73M−54.7% vs Q2 2025 Net Income$8.12M$8.12MN/M vs Q2 2025 EPS Diluted$2.35$2.35N/M vs Q2 2025 Operating Income-$2,101,348N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,067,191N/M Margins · derivedOperating margin-44.5%−40.1 pt vs Q2 2025
Net margin171.9%+174.8 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 24, 2026 · 55 d after period end